99-13332. Cooperative Agreement for Surveillance of Intimate Partner Violence; Notice of Availability of Funds  

  • [Federal Register Volume 64, Number 101 (Wednesday, May 26, 1999)]
    [Notices]
    [Pages 28493-28497]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-13332]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    [Program Announcement 99134]
    
    
    Cooperative Agreement for Surveillance of Intimate Partner 
    Violence; Notice of Availability of Funds
    
    A. Purpose
    
        The Centers for Disease Control and Prevention (CDC) announces the 
    availability of fiscal year (FY) 1999 funds for a cooperative agreement 
    program for Surveillance of Intimate Partner Violence (IPV). This 
    program addresses the ``Healthy People 2000'' priority area of Violent 
    and Abusive Behavior. The purpose of the program is to develop IPV 
    population-based surveillance systems that will help determine the 
    magnitude of the IPV problem in population subgroups, and test its 
    usefulness by comparing resulting data with data from self-report 
    surveys.
    
    B. Eligible Applicants
    
        Assistance will be provided only to the health departments of 
    States or their bona fide agents, including the District of Columbia, 
    the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth 
    of the Northern Mariana Islands, American Samoa, Guam, federally 
    recognized Indian tribal governments, the Federated States of 
    Micronesia, the Republic of the Marshall Islands, and the Republic of 
    Palau. In consultation with States, assistance may be provided to 
    political subdivisions of States.
        Massachusetts, Michigan, and Rhode Island, States currently 
    receiving funds under Announcement No. 483, ``State Injury Intervention 
    Programs,'' are not eligible to apply for this announcement.
    
    C. Availability of Funds
    
        Approximately $600,000 is available in FY 1999 to fund 
    approximately two awards. It is expected that the average award will be 
    $300,000. Ranging from
    
    [[Page 28494]]
    
    $250,000 to $300,000. It is expected that the awards will begin on or 
    about September 30, 1999, and will be made for a 12-month budget period 
    within a project period of up to five years. Funding estimates may 
    change.
        Continuation awards within an approved project period will be made 
    on the basis of satisfactory progress as evidenced by required reports 
    and the availability of funds.
    
    D. Funding Preferences
    
        Preference will be given to those applicants that have jurisdiction 
    over urban areas with a population equal or more than one million. A 
    population of one million or more will provide a large sample size that 
    will allow generalization of the design and methodology of developed 
    IPV Surveillance Systems.
    
    E. Program Requirements
    
        In conducting activities to achieve the purpose of this program, 
    the recipient will be responsible for the activities under 1. 
    (Recipient Activities), and CDC will be responsible for the activities 
    listed under 2. (CDC Activities).
    
    1. Recipient Activities
    
        a. Develop or enhance existing injury surveillance activities to 
    support IPV surveillance to identify victims and occurrences of IPV, 
    including data describing the magnitude of the problem and the extent 
    of injuries (i.e., who is affected, areas and persons at greatest risk, 
    and the type and source of the information used).
        b. Establish a surveillance system, or enhance an existing 
    surveillance system, capable of linking with one or more health-related 
    data sources to determine intimate partner violence incidence and 
    prevalence in the targeted area (e.g., linkage of emergency departments 
    or hospital discharge data with mental health data).
        c. Enhance the capacity of the applicant for general injury 
    surveillance by incorporating the IPV surveillance system with other 
    existing injury surveillance systems.
        d. Design, develop, and implement a health-related surveillance 
    system to measure intimate partner violence and field test CDC's 
    Uniform Definitions and Recommended Data Elements for IPV Surveillance 
    if no surveillance system is in place, or expand currently existing 
    surveillance system to incorporate health-related data and field test 
    the CDC's Uniform Definitions and Recommended Data Elements for IPV 
    Surveillance.
        e. Design, develop and conduct a self-report survey using the same 
    population where the surveillance activities will be conducted.
        f. Establish and maintain cooperative partnerships with key 
    personnel of potential data source agencies (e.g., hospitals, emergency 
    departments, etc.).
        g. Monitor quality, representativeness and completeness of 
    surveillance data.
        h. Collect and analyze surveillance data.
        i. Produce and distribute periodic progress reports and data 
    summaries to appropriate state and local agencies and, develop 
    replication guidelines for future use by other states and localities.
        j. Establish an advisory committee to exchange information and 
    increase the likelihood of integrated injury surveillance systems.
    
    2. CDC Activities
    
        a. Provide technical assistance in the design of all phases of the 
    IPV surveillance programs, including consultation on data collection 
    instruments and procedures.
        b. Provide technical assistance in developing a standardized 
    approach to surveillance and evaluation activities between and among 
    each of the project areas.
        c. Provide consultation and assistance in problem assessment and 
    target population identification, the evaluation of coverage, cost, and 
    impact of surveillance activities, and design of scientific protocols.
        d. Provide consultation on survey designs and IPV surveillance 
    systems for State implementation.
        e. Collaborate in the analysis and dissemination of IPV 
    surveillance data.
        f. Provide up-to-date scientific information about intimate partner 
    violence and coordinate related activities at CDC's National Center for 
    Injury Prevention and Control.
        g. Assist in the transfer of information and methods developed in 
    this program to other geographical areas.
        h. Assist in the development of a research protocol for IRB review 
    by all cooperating institutions participating in the research project. 
    The CDC IRB will review and approve the protocol initially and on at 
    least an annual basis until the research project is completed.
    
    F. Application Content
    
        Use the information in the Program Requirements, Other 
    Requirements, and Evaluation Criteria sections to develop the 
    application content. Your application will be evaluated on the criteria 
    listed, so it is important to follow them in laying out your program 
    plan. The narrative should be no more than 45 double-spaced pages, 
    printed on one side, with one inch margins, and unreduced font.
    
    1. Abstract
    
        A one double-spaced page abstract and summary of the proposed 
    intimate partner violence surveillance system and self-report survey is 
    required.
    
    2. Background and Need
    
        a. The applicant should describe and document the magnitude of the 
    intimate partner violence problem in the applicant's targeted area, and 
    provide a profile of the persons and groups at greatest risk.
        b. The applicant should include a description of its current 
    activities and previous experiences in intimate partner violence 
    surveillance, evaluation, and coordination with other agencies and 
    potential partners.
        c. The applicant should include an assessment of existing injury 
    surveillance capacity.
        d. All information described in this section must be referenced.
    
    3. Goals
    
        a. The applicant should include specific goals which indicate where 
    the applicant anticipates its intimate partner violence surveillance 
    program will be at the end of the five year project period.
        b. The applicant should include a description of and evidence of 
    its willingness and ability to undertake related projects should 
    additional funds become available.
    
    4. Objectives
    
        a. The applicant should include specific time-phased, measurable, 
    and achievable objectives during the first budget period.
        b. The applicant's objectives should relate directly to the project 
    goals, and include, but not be limited to, use of various health-
    related information sources, effort to achieve representativeness, 
    surveillance system evaluation, collaboration, and demonstrate the 
    utility of the surveillance system and self-report survey in 
    replication efforts.
    
    5. Methodology
    
        a. The applicant should also include a detailed description of 
    specific activities that are proposed to achieve each of the program 
    objectives during the budget period. Activities should also include 
    design, development, and administration of a self-report survey for the 
    same population where the surveillance is conducted. Activities should 
    also include how often the self-report survey will be conducted and how 
    will the survey be incorporated as an integral part of the IPV 
    Surveillance System.
    
    [[Page 28495]]
    
        b. The applicant should include a detailed time-line which 
    indicates when each activity and preparations for activities will 
    occur. For each activity, describe who will do what to implement the 
    activities. Specifically provide a description of potential data 
    sources, how these will be accessed, and how some may be linked. If 
    other units or organizations will collaborate, describe the role of the 
    unit or organization, who will be responsible for the designated 
    activities, and explicitly explain how these organizations will deal 
    with privacy and confidentiality issues (e.g., encryption, security, 
    etc.). Document concurrences with this plan by other units or 
    organizations that are collaborating with the applicant.
        c. The applicant should include an organization chart identifying 
    placement of the intimate partner violence surveillance program within 
    organizational units with existing jurisdiction and authority over 
    other injury surveillance systems. The organization chart should also 
    include collaborating components and their relationship to the intimate 
    partner violence surveillance program.
        d. The applicant should include a detailed description of the 
    procedures that makes the applicant compliant with CDC's Policy 
    requirements regarding the inclusion of women, ethnic, and racial 
    groups in the proposed research. The applicant's procedures should 
    include:
        (1) A proposed plan for the inclusion of both sexes and racial and 
    ethnic minority populations for appropriate representation.
        (2) The proposed justification when representation is limited or 
    absent.
        (3) A statement as to whether the design of the study is adequate 
    to measure differences when warranted.
        (4) A statement as to whether the plans for recruitment and 
    outreach for study participants include the process of establishing 
    partnerships with community(ies) and recognition of mutual benefits.
    
    6. Evaluation Plan
    
        a. The applicant should include a detailed description of the 
    methods and design to be used to evaluate the IPV surveillance system, 
    including what will be evaluated, data to be used, who will perform the 
    evaluation and the time it will take (timeline) to do the evaluation. 
    Specifically address the sensitivity, usefulness, simplicity, 
    flexibility, acceptability, timeliness, representativeness, predictive 
    value positive, and cost.
        b. The applicant should document staff availability, expertise, and 
    capacity to evaluate surveillance activities. The evaluation should 
    include development of tools and data set structures that will enable 
    the IPV surveillance system, design of self-report survey instruments, 
    and other relevant activities such as, training of hospital staff to 
    identify and collect IPV data, and evaluation of software applications 
    and computer equipment. The evaluation should also include progress in 
    meeting the objectives and conducting activities during the budget and 
    project periods.
    
    7. Coordination and Collaboration
    
        a. The applicant should include a description of the relationship 
    between the program and other organizations, agencies, and health 
    department units that will relate to the program, or which conduct 
    related activities. Include composition and roles of any state and/or 
    local coalitions involved with the applicant in developing the IPV 
    surveillance system and self-report survey; specific commitments of 
    support to provide staff, equipment, space, time, etc.
        b. The applicant should include a description of any proposed 
    collaboration with academic institutions, public safety officials, or 
    with other agencies should be included. In addition, a description of 
    the responsibilities and composition of the surveillance advisory 
    committee should be included in this section.
    
    8. Project Management and Staffing
    
        a. The applicant should include a description of the roles and 
    responsibilities of the project director, epidemiologist, and each 
    staff member, including a description of staff with appreciable 
    experience in other injury surveillance systems expected to work in the 
    IPV Surveillance System.
        b. The applicant should describe the allocation of staff to the 
    activities described in the Methodology section. Descriptions should 
    include the position titles, education and experience required, and the 
    percentage of time each will devote to the program. In addition, the 
    description should also state the methods the staff will employ to 
    train others to collect and manage IPV data. Curriculum vitae for 
    existing staff should also be included.
        c. In an appendix, the applicant should provide a letter from each 
    collaborating consultant or outside agency described in the Methodology 
    section. The letter should state their willingness and ability to 
    fulfill the proposed responsibilities.
    
    9. Budget
    
        The applicant should provide a detailed first budget with 
    accompanying narrative justifying all individual budget items which 
    make up the total amount of funds requested. The budget should be 
    consistent with stated objectives and planned activities.
    
    10. Human Subjects
    
        a. The applicant should describe the degree to which human subjects 
    may be at risk and what protections will be in place to assure 
    protections and confidentiality.
        b. The applicant should demonstrate that it has adequately 
    addressed the requirements of Title 45 CFR Part 46 for the protection 
    of human subjects.
    
    G. Submission and Deadline
    
        Submit the original and two copies of PHS 5161-1 (OMB Number 0937-
    0189). Forms are in the application kit.
        On or before July 19, 1999, submit the application to the Grants 
    Management Specialist identified in the ``Where To Obtain Additional 
    Information'' section of this announcement.
    
    1. Deadline
    
        Applications shall be considered as meeting the deadline if they 
    are either:
        (a) Received on or before the deadline date; or
        (b) Sent on or before the deadline date and received in time for 
    orderly processing. (Applicants must request a legibly dated U.S. 
    Postal Service postmark or obtain a legibly dated receipt from a 
    commercial carrier or U.S. Postal Service. Private metered postmarks 
    shall not be acceptable as proof of timely mailing.)
    
    2. Late Applications
    
        Applications which do not meet the criteria in (a) or (b) above are 
    considered late applications, will not be considered, and will be 
    returned to the applicant.
    
    H. Evaluation Criteria
    
        Each application will be evaluated individually against the 
    following criteria by an independent review group appointed by CDC.
    
    1. Background and Need (10 points)
    
        a. The extent to which the applicant documents the magnitude of the 
    intimate partner violence problem in the applicant's targeted area, and 
    provides a profile of the persons and groups at greatest risk.
        b. The extent to which the applicant documents its current 
    activities and previous experiences in intimate partner violence 
    surveillance, evaluation, and coordination with other agencies and 
    potential partners.
    
    [[Page 28496]]
    
        c. The extent to which the applicant has made a complete assessment 
    of existing injury surveillance capacity.
    
    2. Goals (15 points)
    
        a. The extent to which the applicant states specific goals that 
    indicate where the applicant anticipates its intimate partner violence 
    surveillance program will be at the end of the five year project 
    period.
        b. The extent to which the applicant describes and provides 
    evidence of its willingness and ability to undertake related projects 
    should additional funds become available.
    
    3. Objectives (15 points)
    
        a. The extent to which the applicant states specific, time-phased, 
    measurable and achievable objectives.
        b. The extent to which the applicant relates the objectives 
    directly to the project goals and the use of various health-related 
    information sources, effort to achieve representativeness, surveillance 
    system evaluation, collaboration, and demonstrates the utility of the 
    surveillance system and self-report survey in replication efforts.
    
    4. Methodology (15 points)
    
        a. The extent to which the applicant describes specific activities 
    that are proposed to achieve each of the program objectives during the 
    budget period.
        b. The extent to which the applicant provides a time-line which 
    indicates when each activity and preparations for activities will 
    occur.
        c. The extent to which the applicant provides evidence of an 
    organizational chart that represents the actual structure of the 
    proposed IPV surveillance operating organization and its placement in 
    organizational units with existing jurisdiction and authority over 
    other injury surveillance systems.
        d. The extent to which the applicant provides evidence it has met 
    the CDC Policy requirements regarding the inclusion of women, ethnic, 
    and racial groups in the proposed research.
    
    5. Evaluation Plan (15 points)
    
        a. The extent to which the applicant describes the methods and 
    design to be used to evaluate the IPV surveillance system, including 
    what will be evaluated, data to be used, who will perform the 
    evaluation and the time it will take (timeline) to do the evaluation.
        b. The extent to which the applicant provides evidence of staff 
    availability, expertise, and capacity to evaluate surveillance 
    activities.
    
    6. Coordination and Collaboration (15 points)
    
        a. The extent to which the applicant describes the relationship 
    between the program and other organizations, agencies, and health 
    department units that will relate to the program or which conduct 
    related activities.
        b. The extent to which applicant provides evidence of collaboration 
    with academic institutions, public safety officials, or with other 
    agencies. In addition, the extent to which the applicant describes 
    responsibilities and composition of the surveillance advisory 
    committee.
    
    7. Project Management and Staffing (15 points)
    
        a. The extent to which the applicant documents the experience in 
    the management of intimate partner violence surveillance, and describes 
    the roles and responsibilities of the project director, epidemiologist, 
    and each staff member, including a description of staff with 
    appreciable experience in other injury surveillance systems expected to 
    work in the IPV Surveillance System.
        b. The extent to which the applicant includes letters in the 
    appendix from each collaborating consultant or outside agency stating 
    their willingness and ability to fulfill the proposed responsibilities.
    
    8. Budget (Not scored)
    
        The extent to which the budget request is clearly explained, 
    adequately justified, reasonable, sufficient, and consistent with the 
    stated objectives and planned activities.
    
    9. Human Subjects (Not scored)
    
        a. The extent to which the applicant describes the degree to which 
    human subjects may be at risk.
        b. The extent to which the applicant provides assurances that all 
    activities will conform to the requirements of 45 CFR, part 46.
    
    I. Other Requirements
    
        Technical Reporting Requirements:
        Provide CDC with original plus two copies of
        1. Progress reports (semiannual);
        2. Financial status report, no more than 90 days after the end of 
    the budget period; and
        3. Final financial and performance reports, no more than 90 days 
    after the end of the project period.
        Send all reports to the Grants Management Specialist identified in 
    the ``Where to Obtain Additional Information'' section of this 
    announcement.
        The following additional requirements are applicable to this 
    program. For a complete description of each, see Addendum in the 
    application package.
    
    AR-1  Human Subjects Requirements
    AR-2  Requirements for Inclusion of Women and Racial and Ethnic 
    Minorities in Research
    AR-7  Executive Order 12372 Review
    AR-9  Paperwork Reduction Act Requirements
    AR-10  Smoke-Free Workplace Requirements
    AR-11  Healthy People 2000
    AR-12  Lobbying Restrictions
    AR-13  Prohibition on Use of CDC Funds for Certain Gun Control 
    Activities
    
    J. Authority and Catalog of Federal Domestic Assistance Number
    
        This program is authorized under sections 301, 317k(2), and 391-394 
    of the Public Health Service Act, [42 U.S.C. 241, 247b(k)(2), and 280-
    280b-2], as amended. The Catalog of Federal Domestic Assistance number 
    is 93.136.
    
    K. Where To Obtain Additional Information
    
        This and all other CDC Announcements may be found and downloaded 
    from the CDC homepage. Internet address: http://www.cdc.gov (click on 
    funding).
        To receive additional written information and to request an 
    application kit, call 1-888-GRANTS4 (1-888-472-6874). You will be asked 
    to leave your name and address and will be instructed to identify the 
    Announcement number of Interest.
        If you have questions after reviewing the contents of all the 
    documents, business management technical assistance may be obtained 
    from:
        Ricky Willis, Grants Management Specialist, Grants Management 
    Branch, Procurement and Grants Office, Announcement 99134, Centers for 
    Disease Control and Prevention, 2920 Brandywine Road, Suite 3000, 
    Mailstop E-13, Atlanta, GA 30341-4146, Telephone: (770) 488-2719, E-
    mail address: rqw0@cdc.gov
        For program technical assistance contact: Enrique Nieves, Project 
    Officer, National Center for Injury Prevention and Control, Centers for 
    Disease Control and Prevention, 4770 Buford Highway, N.E., Mailstop K-
    63, Atlanta, GA 30341, Telephone: (770) 488-1281, E-mail address: 
    exn2@cdc.gov
    
    
    [[Page 28497]]
    
    
        Dated: May 20, 1999.
    John L. Williams,
    Director, Procurement and Grants Office, Centers for Disease Control 
    and Prevention (CDC).
    [FR Doc. 99-13332 Filed 5-25-99; 8:45 am]
    BILLING CODE 4163-18-P
    
    
    

Document Information

Published:
05/26/1999
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
99-13332
Pages:
28493-28497 (5 pages)
Docket Numbers:
Program Announcement 99134
PDF File:
99-13332.pdf